|
시장보고서
상품코드
1983177
심장 임플란트 시장 : 디바이스 유형별, 용도별, 최종사용자별, 지역별Cardiac Implants Market, By Device Type, By Application, By End User, By Geography |
||||||
심장 임플란트 시장은 2026년에 488억 6,200만 달러로 추정되며, 2033년에는 834억 9,000만 달러에 이를 것으로 예측됩니다. 또한, 2026-2033년 CAGR 8%로 성장할 전망입니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 488억 6,200만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2025-2032년) | 8.00% | 예측 금액(2033년) | 834억 9,000만 달러 |
심장 임플란트는 부정맥을 조절하고 감지하는 데 사용됩니다. 심장 임플란트에는 양심실 심박조율기, 심박조율기, 이식형 제세동기(ICD), 심장 루프 레코더 등이 포함됩니다. 심장 임플란트제조에 사용되는 생체 재료에는 바이오 세라믹, 폴리머, 복합재료, 금속 및 그 합금이 포함됩니다. 이식형 제세동기는 기존 ICD와 피하 ICD(S-ICD)의 두 가지로 분류됩니다. 미국 식품의약국(U.S. FDA)이 승인한 심장질환 치료 의료기기는 자동심장충격기(AED), 심장절제 카테터, 심장혈관성형술용 장치, 심장박동기, 이식형 제세동기(ICD), 인공심장판막, 스텐트, 심실보조장치(VAD) 등 8가지다. 8가지 유형이 있습니다. 심박조율기, 이식형 제세동기(ICD), 심장재동기화요법(CRT) 장치와 같은 심장 이식형 전기장치는 심장질환 치료에 널리 사용되고 있습니다. 또한, 심박조율기에는 단실형 심박조율기와 양실형 심박조율기의 두 가지 유형이 있습니다.
시장 역학
심장 임플란트 시장에서 사업을 전개하는 주요 기업들은 첨단 기술을 기반으로 한 신제품을 출시하고 있으며, 이는 심장 임플란트 시장의 성장에 기여하고 있습니다. 예를 들어, 2022년 4월 중국 기반 심장 리듬 관리 기업 MicroPort CRM은 자사의 Ulys 및 Edis ICD에 대해 유럽연합(EU)으로부터 MRI 대응 CE 마크 승인을 획득했다고 발표했습니다. 이 새로운 ICD는 저전류 소비를 실현하는 첨단 기술을 접목한 고전압 디바이스로, 결과적으로 디바이스의 수명을 연장할 수 있습니다. 이러한 노력의 강화와 혁신적인 기술이 시장을 주도하는 새로운 전략으로 떠오르고 있는 것으로 보입니다. 따라서 첨단 심장 이식 장치의 출시는 예측 기간 동안 시장 성장을 가속할 것으로 예측됩니다.
본 보고서의 주요 특징
- 세계의 심장 임플란트 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
- 또한, 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한, 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
- 세계 심장 임플란트 시장의 주요 기업 프로파일을 기업 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등의 매개 변수를 기반으로 정리하여 수록했습니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- "세계 심장 임플란트 시장" 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 심장 임플란트 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 심장 임플란트 시장 : 디바이스 유형별(2026년-2033년)
제5장 세계의 심장 임플란트 시장 : 용도별(2026년-2033년)
제6장 세계의 심장 임플란트 시장 : 최종사용자별(2026년-2033년)
제7장 세계의 심장 임플란트 시장 : 지역별(2026년-2033년)
제8장 히트맵 분석
제9장 섹션
LSH 26.04.17Cardiac Implants Market is estimated to be valued at USD 48,862 Mn in 2026 and is expected to reach USD 83,490 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 48,862 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.00% | 2033 Value Projection: | USD 83,490 Mn |
An implantable cardiac devices is used to regulate and detect irregular heartbeat. The implantable cardiac device includes biventricular pacemakers, pacemakers, implantable cardioverter defibrillator (ICD), and cardiac loop recorders. Biomaterial used in manufacturing cardiac implants are biocreamics, polymers, composite materials, metals and their alloys. The implantable cardioverter-defibrillator is categorized into two types namely traditional ICD and subcutaneous ICD (S-ICD). There are eight types of U.S. Food and Drug Administration (U.S. FDA) approved devices that treat the heart disorders such as automated external defibrillators (AEDs), cardiac ablation catheters, cardiovascular angioplasty devices, cardiac pacemakers, implantable cardioverter defibrillators (ICDs), prosthetic (artificial) heart valves, stents, ventricular assist devices (VADs). Cardiac implantable electric device such as pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices are extensively used for cardiac disorders. Furthermore, there are two types of pacemakers used single chamber pacemaker and dual-chamber pacemaker.
Market Dynamics
Key players operating in cardiac implants market are launching new products based on advanced technologies, which is contributing to growth of the cardiac implants market. For instance, in April 2022, MicroPort CRM, a China-based cardiac rhythm management announced that it received MRI-conditional CE mark approval from the European Union for its Ulys and Edis ICDs. These new ICDs are high-voltage devices incorporated with advanced technology which allows low current consumption, resulting in long lifespan of the devices. The increasing efforts and innovative technologies are seen to emerge new strategy for driving the market. Hence, the launch of the advanced cardiac implants is expected to drive the market growth over the forecast period.
Key features of the study
- This report provides an in-depth analysis of the global cardiac implants market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cardiac implants market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
- Key companies covered as a part of this study include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Edwards Lifesciences Corporation, Meril Life Sciences Pvt. Ltd., Lepu Medical Technology (Beijing) Co., Ltd., BIOTRONIK SE & Co. KG, OSYPKA MEDICAL, Pacetronix.com, Vitatron, Terumo Corporation, Cordis, MicroPort Scientific Corporation.
- Global cardiac implants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have an ease in decision-making through various strategy matrices used in analysing the global cardiac implants market
Market Segmentation
- Device Type Insights (Revenue, USD Mn, 2026 - 2033)
- Pacemaker Devices
- Cardiac Resynchronization Therapy Devices
- Implantable Hemodynamic Monitoring Devices
- Implanted Heart Rhythm Monitors
- Coronary Stents
- Implantable Cardioverter Defibrillator
- Heart Valve
- Others
- Application Insights (Revenue, USD Mn, 2026 - 2033)
- Arrhythmias
- Myocardial Ischemia
- Acute Myocardial Infraction
- Congestive Heart Failure
- Others
- End User Insights (Revenue, USD Mn, 2026 - 2033)
- Hospitals
- Specialty Clinics
- Others
- Regional Insights (Revenue, USD Mn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Abbott Laboratories
- Braun Melsungen AG
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- Meril Life Sciences Pvt. Ltd.
- Lepu Medical Technology (Beijing) Co., Ltd.
- BIOTRONIK SE & Co. KG
- OSYPKA MEDICAL
- Pacetronix.com
- Vitatron
- Terumo Corporation
- Cordis
- MicroPort Scientific Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Device Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Market Trends
- Key Developments
- Technology Advancements
- Substitutes/Alternatives
- Epidemiology
- Electronic Components of Cardiac Implants
- Overview of Sensors used in Cardiac Implants
- Risk of Infection
- Partnerships and Acquisitions
- Regulatory Scenario
- PORTER'S Five Forces
- PEST Analysis
- Brand and Distributor Analysis
- Pricing Analysis
- Product Recalls
- Number of Hospitals and Ambulatory Surgery Centers, by Country
- Number of Procedures/Surgeries by Country
4. Global Cardiac Implants Market, By Device Type, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Pacemaker Devices
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Cardiac Resynchronization Therapy Devices
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Implantable Hemodynamic Monitoring Devices
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Implanted Heart Rhythm Monitors
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Coronary Stents
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Implantable Cardioverter Defibrillator
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Heart Valve
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
5. Global Cardiac Implants Market, By Application, 2026-2033, (USD Mn)
- Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Arrhythmias
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Myocardial Ischemia
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Acute Myocardial Infraction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Congestive Heart Failure
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
6. Global Cardiac Implants Market, By End User, 2026-2033, (USD Mn)
- Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Specialty Clinics
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
7. Global Cardiac Implants Market, By Region, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Device Type, 2026-2033, (USD Mn)
- Market Size and Forecast, By Application, 2026-2033, (USD Mn)
- Market Size and Forecast, By End User, 2026-2033, (USD Mn)
- Market Size and Forecast, By Country, 2026-2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Device Type, 2026-2033, (USD Mn)
- Market Size and Forecast, By Application, 2026-2033, (USD Mn)
- Market Size and Forecast, By End User, 2026-2033, (USD Mn)
- Market Size and Forecast, By Country, 2026-2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Device Type, 2026-2033, (USD Mn)
- Market Size and Forecast, By Application, 2026-2033, (USD Mn)
- Market Size and Forecast, By End User, 2026-2033, (USD Mn)
- Market Size and Forecast, By Country, 2026-2033, (USD Mn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Device Type, 2026-2033, (USD Mn)
- Market Size and Forecast, By Application, 2026-2033, (USD Mn)
- Market Size and Forecast, By End User, 2026-2033, (USD Mn)
- Market Size and Forecast, By Country, 2026-2033, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Device Type, 2026-2033, (USD Mn)
- Market Size and Forecast, By Application, 2026-2033, (USD Mn)
- Market Size and Forecast, By End User, 2026-2033, (USD Mn)
- Market Size and Forecast, By Country, 2026-2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Device Type, 2026-2033, (USD Mn)
- Market Size and Forecast, By Application, 2026-2033, (USD Mn)
- Market Size and Forecast, By End User, 2026-2033, (USD Mn)
- Market Size and Forecast, By Country, 2026-2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
8. Heat Map Analysis
- Company Profile
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- B. Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Edwards Lifesciences Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Meril Life Sciences Pvt. Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lepu Medical Technology (Beijing) Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BIOTRONIK SE & Co. KG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- OSYPKA MEDICAL
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pacetronix.com
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Vitatron
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cordis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- MicroPort Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
